In addition, FGF21 ameliorates myocardial damage in diabetes by activating AMPK-AKT2-Nrf2-mediated antioxidant pathways and AMPK-ACC-CPT1-mediated lipid-lowering effects (91). The gene discussed is FGF21; the disease is diabetes mellitus.